Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-047802
Filing Date
2023-04-20
Accepted
2023-04-20 16:32:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 tm239007-7_424b3.htm 424B3 4677633
2 GRAPHIC lg_adaptimmune-4c.jpg GRAPHIC 65407
3 GRAPHIC lg_tcr-4c.jpg GRAPHIC 20631
4 GRAPHIC lg_pipersandler-4c.jpg GRAPHIC 13231
  Complete submission text file 0001104659-23-047802.txt   4815759
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271145 | Film No.: 23833553
SIC: 2836 Biological Products, (No Diagnostic Substances)